Keyphrases
Polymorphism
100%
Pharmacogenetics
100%
Cytochrome
100%
Cytochrome P450 3A (CYP3A)
100%
Adenosine Triphosphate-binding Cassette
100%
Tacrolimus Pharmacokinetics
100%
Tacrolimus
83%
CYP3A5
83%
Renal Transplant Recipients
66%
Variant Allele
66%
Pharmacokinetic Parameters
50%
Cytochrome P450 3A4 (CYP3A4)
50%
Transplantation
33%
Median Range
33%
Transplant Recipients
33%
CYP3A Polymorphisms
33%
Area under the Curve
16%
High Dose
16%
No Significant Difference
16%
Genotype
16%
Allele Frequency
16%
Daily Dose
16%
Organ Transplantation
16%
Immunosuppressive Therapy
16%
Dose Assessment
16%
Maximum Permissible Concentration
16%
P-glycoprotein (P-gp)
16%
Trough Level
16%
Transplant Patients
16%
Pharmacokinetic Variability
16%
Normalized Area
16%
Narrow Therapeutic Range
16%
Tacrolimus Metabolism
16%
INIS
doses
100%
transplants
100%
cytochromes
100%
adenosine triphosphate
100%
kidneys
57%
patients
42%
range
42%
carriers
42%
levels
14%
curves
14%
therapy
14%
comparative evaluations
14%
assessments
14%
metabolism
14%
genotype
14%
concentration
14%
enzymes
14%
organs
14%
glycoproteins
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
100%
Cytochrome
100%
Tacrolimus
100%
Pharmacokinetics
100%
Pharmacogenetics
100%
Cytochrome P450 3A5
71%
Pharmacokinetic Parameter
42%
Immunosuppressive Agent
28%
CYP3A4
28%
CYP3A
28%
Trough Level
14%
P-Glycoprotein
14%
Immunology and Microbiology
Transplant Procedure
100%
Tacrolimus
100%
Pharmacokinetics
100%
Pharmacogenetics
100%
Allele
85%
Genotype
14%
Organ Transplantation
14%
Immunosuppressant
14%
Immunosuppressive Drug
14%
Immunosuppressive Therapy
14%
Haplotype
14%
Gene Frequency
14%
Drug Megadose
14%
P-Glycoprotein
14%